Logo

American Heart Association

  39
  0


Final ID:

Cardiac Myosin Inhibitors in HCM - Altering The Natural History or Am I Delusional?

  • Owens, Anjali  ( UNIVERSITY OF PENN , Walliford , Pennsylvania , United States )
  • Olivotto, Iacopo  ( Meyer Children’s Hospital IRCCS , Florence , Italy )
  • Author Disclosures:
    Anjali Owens: DO have relevant financial relationships ; Consultant:Alexion:Active (exists now) ; Consultant:Stealth:Active (exists now) ; Consultant:Corvista:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Consultant:Lexeo:Active (exists now) ; Consultant:Imbria:Active (exists now) ; Consultant:Edgewise:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Avidity:Active (exists now) ; Consultant:BMS:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Consultant:Bayer:Active (exists now) | Iacopo Olivotto: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

More abstracts on this topic:
TN-201, an Investigational MYBPC3 Gene Replacement Therapy: Interim Clinical Data from MyPEAK-1, a Phase Ib/2a Study Evaluating Safety and Early Efficacy of TN-201 in Adult Patients with MYBPC3-Associated Hypertrophic Cardiomyopathy

Desai Milind, Paterson Natasha, Ivey Kathy, Tingley Whittemore, Nagueh Sherif, Giudicessi John, Pollman Matt, Varfaj Bardha, Harrison William, Lombardi Laura, Argast Gretchen, Tomlinson Latanya

Surgical innovations in HCM: More Than Just A Shave?

Quintana Eduard, Wei Xiang

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available